#SRDX QTR DATE FULL#

This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. 7 Commodities ETFs to Help Build a Hedge Against Inflation.7 Dividend Stocks That Earn 10% Every Month.7 Dividend Aristocrats to Help You Take the Bite Out of the Bear (NASDAQ:SRDX) shareholders might be concerned after seeing the share price drop 10 in the last quarter.10 Recession-Proof Stocks That Will Let You Wait Out the Bear.7 Stocks with the Pricing Power to Push Through High Inflation.7 Blue-Chip Dividend Stocks That Won’t be Impacted by Rising Interest Rates.7 Mid-Cap Stocks That Can be the Perfect Fit at Any Time.7 Stocks to Buy to Outrun Rising Interest Rates.Earnings were 4.24 million, an increase of 277.29.

#SRDX QTR DATE FULL#

7 Sports Betting Stocks to Buy for Their Long-Term Possibilities IPO Date CEO Gary Maharaj Employees 389 Stock Exchange NASDAQ Ticker Symbol SRDX Full Company Profile Financial Performance In 2021, SurModics's revenue was 105.14 million, an increase of 10.83 compared to the previous year's 94.86 million.7 Water Stocks to Buy as the World Dries Up.7 Solar Stocks Leading the Clean Energy Boom.Inflation Doesn’t Differentiate, But it’s Impact Does.Why These 3 Stocks Are Off to Hot September Starts.Darden Restaurants Takes the Low Road Against Inflation.Do These Dividend Achievers Deserve A Place In Your Portfolio?.3 Energy Stocks Nearing Breakouts From Cup-Shaped Patterns.Three Value Stocks For A Volatile Market.The Two Things You Need To Know About Oracle’s FQ1 Report.This Is What To Expect From The S&P 500 Now.These 3 Reports Will Tell Us Much About the Current Economy.Is Five Below Trying to Punch Too High?.The Trader's Guide to Equities Research.

Srdx qtr date